• CXI Healthcare Technology Group corrected its shareholder meeting notice on Oct. 20, 2026, to reflect external audit results.
• Share capital was reclassified separately from share premium at CNY 28.53 million, versus the previously combined CNY 1.03 billion.
• Net income remained CNY 38.9 million for the year ended June 30, 2026.
• The corrected disclosure added cash flow and equity statements, showing net investing cash outflows of CNY 1.02 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CXI Healthcare Technology Group Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261020000194), on October 20, 2026, and is solely responsible for the information contained therein.